Merck to submit Cladribine for Euro registration

Mavenclad is an oral treatment for relapsing MS and active secondary progressive MS.
Post Reply
User avatar
MSUK
Family Elder
Posts: 2903
Joined: Wed Oct 14, 2009 2:00 pm
Contact:

Merck to submit Cladribine for Euro registration

Post by MSUK » Fri Sep 11, 2015 5:48 am

German healthcare firm Merck has announced it is to submit its investigational treatment Cladribine Tablets for the treatment of relapsing MS for registration in Europe. The decision follows the company’s evaluation of new data and additional analyses of the compound’s benefit-risk profile....Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/

Post Reply
  • Similar Topics
    Replies
    Views
    Last post